Literature DB >> 9113536

Relationship between mortality rates and hospital patient volume for Medicare patients undergoing major orthopaedic surgery of the hip, knee, spine, and femur.

H D Taylor1, D A Dennis, H S Crane.   

Abstract

This study examines the relationship between mortality rates and hospital patient volume for major orthopaedic surgery. All Medicare patients from fiscal years 1993 and 1994 in diagnosis-related groups (DRGs) 209, 210, and 214 were included, covering hip and knee arthroplasty, other hip and femur procedures, and spine procedures. Within DRG 209, five procedures were studied in more detail: total hip arthroplasty, partial hip arthroplasty, revision total hip arthroplasty, total knee arthroplasty, and revision total knee arthroplasty. Higher-volume hospitals had lower mortality rates, both in-house and in-house plus 30-day, for each of the DRGs studied and for each of the individual procedures within DRG 209. Age and sex were examined as potential causes of the differences in mortality rates, but no attempt was made to adjust for comorbidities or orthopaedic degree of difficulty. Results for 1995 are included in an appendix.

Entities:  

Mesh:

Year:  1997        PMID: 9113536     DOI: 10.1016/s0883-5403(97)90018-8

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  27 in total

1.  Relation of surgical volume to outcome in eight common operations: results from the VA National Surgical Quality Improvement Program.

Authors:  S F Khuri; J Daley; W Henderson; K Hur; M Hossain; D Soybel; K W Kizer; J B Aust; R H Bell; V Chong; J Demakis; P J Fabri; J O Gibbs; F Grover; K Hammermeister; G McDonald; E Passaro; L Phillips; F Scamman; J Spencer; J F Stremple
Journal:  Ann Surg       Date:  1999-09       Impact factor: 12.969

2.  The relation of volume with outcome in phacoemulsification surgery.

Authors:  M Habib; K Mandal; C V Bunce; S G Fraser
Journal:  Br J Ophthalmol       Date:  2004-05       Impact factor: 4.638

Review 3.  [A rapid review of the minimum quality problems using total knee arthroplasty as an example. Where do the magical threshold values come from?].

Authors:  D Stengel; A Ekkernkamp; J Dettori; B Hanson; K M Stürmer; H Siebert
Journal:  Unfallchirurg       Date:  2004-10       Impact factor: 1.000

4.  [Minimum requirements in total knee replacement. Evidence report and model calculation of the healthcare situation].

Authors:  P Schräder; T Rath
Journal:  Orthopade       Date:  2005-03       Impact factor: 1.087

5.  Reverse total shoulder replacement: intraoperative and early postoperative complications.

Authors:  Carl Wierks; Richard L Skolasky; Jong Hun Ji; Edward G McFarland
Journal:  Clin Orthop Relat Res       Date:  2008-08-07       Impact factor: 4.176

Review 6.  A review of the role of simulation in developing and assessing orthopaedic surgical skills.

Authors:  Geb W Thomas; Brian D Johns; J Lawrence Marsh; Donald D Anderson
Journal:  Iowa Orthop J       Date:  2014

7.  Effects of Postacute Settings on Readmission Rates and Reasons for Readmission Following Total Knee Arthroplasty.

Authors:  Rodney Laine Welsh; James E Graham; Amol M Karmarkar; Natalie E Leland; Jacques G Baillargeon; Dana L Wild; Kenneth J Ottenbacher
Journal:  J Am Med Dir Assoc       Date:  2017-02-14       Impact factor: 4.669

8.  Epidemiology of multiligament knee reconstruction.

Authors:  Sean M Wilson; Nabil Mehta; Huong T Do; Hassan Ghomrawi; Stephen Lyman; Robert G Marx
Journal:  Clin Orthop Relat Res       Date:  2014-09       Impact factor: 4.176

9.  Risk factors for adverse outcomes after the surgical treatment of appendicitis in adults.

Authors:  Julie A Margenthaler; Walter E Longo; Katherine S Virgo; Frank E Johnson; Charles A Oprian; William G Henderson; Jennifer Daley; Shukri F Khuri
Journal:  Ann Surg       Date:  2003-07       Impact factor: 12.969

10.  Modeling the volume-effectiveness relationship in the case of hip fracture treatment in Finland.

Authors:  Reijo Sund
Journal:  BMC Health Serv Res       Date:  2010-08-13       Impact factor: 2.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.